How Do Doctors Define Progressive Fibrosis in Fibrotic NSIP?

To determine if fibrotic NSIP has become progressive pulmonary fibrosis (PPF), doctors look for a pattern of specific changes over a 12-month period. Progressive pulmonary fibrosis is not a separate new disease; rather, it is a clinical term used to describe when an underlying interstitial lung disease (like fibrotic NSIP) is behaving aggressively and continuing to worsen ^[1]. According to the 2022 guidelines from major international lung societies (ATS/ERS/JRS/ALAT), a patient meets the criteria for PPF if they have at least two out of three progression domains—worsening respiratory symptoms, declining lung function, and worsening scarring on a CT scan—within the past year, with no other medical explanation for these changes ^[1][2].

The Three Progression Criteria

To qualify as PPF, your condition must meet at least two of the following three criteria within a recent one-year look-back window ^[1]:

1. Worsening Respiratory Symptoms

This is a clinical assessment of how you feel on a daily basis. It generally means you are experiencing an increased shortness of breath or a worsening cough during activities you used to handle well ^[2][3]. There is no single “symptom score” required; it relies on your description to your care team ^[2].

Safety Note: While gradual worsening might be a sign of PPF, sudden or rapidly worsening breathlessness, chest pain, fainting, confusion, or blue lips are medical emergencies. Seek urgent medical care for these symptoms, as they could indicate a blood clot, severe infection, or an acute exacerbation ^[4].

2. Physiologic Decline (Lung Function Tests)

Doctors look for specific drops in your pulmonary function tests (PFTs). To meet this criterion, you must have an absolute decline in either of two key measurements ^[2]:

• Forced Vital Capacity (FVC): This measures how much air you can forcefully exhale. The threshold is a drop of at least 5 percentage points in your percent-predicted FVC ^[2].
• Diffusing Capacity for Carbon Monoxide (DLCO): This estimates how well oxygen moves from your lungs into your bloodstream. The threshold is a drop of at least 10 percentage points in your percent-predicted DLCO ^[2].

Understanding “Absolute Decline”: An absolute decline refers to a straightforward subtraction. If your FVC was 70% of what was predicted a year ago and is 65% today, that is a 5 percentage point absolute decline ^[5][6].

Important Caveat: For a drop in DLCO to be reliable, it must be corrected for hemoglobin ^[7]. Conditions like anemia (low red blood cells) can artificially lower your DLCO score, making it look like your fibrosis is progressing when it isn’t. Doctors also consider your effort during the test and whether the testing equipment was consistent.

3. Radiologic Progression (Chest CT)

This means a high-resolution CT scan shows worsening fibrotic changes compared to your previous scans. Because CT changes can be subtle, this is best determined by a radiologist experienced with interstitial lung diseases. Examples of progression include a wider spread of scarring (reticulation), new “honeycombing” (clusters of cysts), or worsening traction bronchiectasis (where scar tissue pulls the airways open and distorts them) ^[8][9].

Why One Bad Test Isn’t Enough

One of the most important rules of the PPF definition is that there must be no alternative explanation for your declining health ^[1].

A single abnormal test result or a few bad weeks of shortness of breath does not automatically mean your NSIP is progressing. For example, a drop in DLCO might be caused by pulmonary hypertension (high blood pressure in the lungs) or emphysema ^[10][7]. Worsening breathlessness could be due to a blood clot, an infection, or drug toxicity ^[4][11]. Doctors must investigate and assess whether another condition better explains these changes before confirming the PPF pattern ^[1].

The Role of Walking Tests and Oxygen

You might notice that your performance on a 6-minute walk test or your need for supplemental oxygen are not on the formal list of criteria. While exertional oxygen desaturation (dropping oxygen levels during exercise) and declining walk distance do not definitively prove the lung fibrosis itself is progressing, they remain highly valuable for assessing the severity of your condition and your treatment needs ^[12][13].

The guidelines exclude them as formal threshold criteria because walking distance and oxygen levels can be heavily influenced by age, muscle deconditioning, joint problems, or heart conditions ^[14][15]. However, they provide vital supportive information, and you should always report increasing oxygen use or reduced activity tolerance to your doctor.

What Progression Means for Your Care

If your fibrotic NSIP meets the criteria for PPF, it indicates that the disease is behaving progressively after other explanations have been ruled out. Hearing the word “progression” can be frightening, but this criteria framework is simply a tool to guide your monitoring and treatment discussions.

Confirming PPF does not necessarily mean your current immunosuppressive treatments have failed, but it often prompts a highly individualized discussion about your treatment plan ^[1]. Your doctor may discuss adding an antifibrotic medication (such as nintedanib). Antifibrotics do not remove existing scar tissue or cure the disease; their goal is to slow down the rate of further lung function decline. The decision to use these medications depends on local guidelines, your specific health history, potential side effects, and ongoing immunosuppression needs.